InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Explore the complete record of transactions filed by Hoerter Steven L., Chief Executive Officer. Director active across 2 companies, notably Deciphera Pharmaceuticals, Inc.. In total, 8 disclosures have been recorded. Breakdown: 1 buy · 2 sells. Total volume traded: €783k. Activity tracked since 21 March 2022. The latest transaction was disclosed on 3 August 2026 (Attribution). Regulator: SEC (Form 4). The full history is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
8 of 8 declarations
Steven L. Hoerter is the President and Chief Executive Officer of Deciphera Pharmaceuticals, Inc. He leads the company and oversees its overall strategy. His experience in the pharmaceutical sector is essential for the company's development.